Anti-Cyclic Citrullinated Peptide (CCP) Antibodies
Rapid CDIATM anti-CCP Antibodies kits are intended for the detection of anti-CCP antibodies in vitro in aid of the diagnosis of rheumatoid arthritis.
Anti-CCP is an auto-antibody produced by the patient’s immune system that attacks the body. These attacks can produce inflammatory symptoms most commonly experienced in rheumatoid arthritis. Testing for the presence of anti-CCP is a relatively new support tool in helping doctors diagnose rheumatoid arthritis. Prior to the discovery of anti-CCP and the testing of it, most doctors used rheumatoid factor – another antibody – as a test to help reach a rheumatoid arthritis diagnosis. Anti-CCP is thought to be present in 60% to 70% of patients with rheumatoid arthritis. Anti-CCPs can also exist in a patient for years before they ever develop clinical rheumatoid arthritis symptoms. Anti-CCP positive testing is also used to help doctors deliver a prognosis because many anti-CCP positive patients experience severe rheumatoid arthritis symptoms. Testing positive for anti-CCP also helps doctors pursue specific treatment options.